Literature DB >> 22828320

Investigation on PLK2 and PLK3 substrate recognition.

M Salvi1, E Trashi, G Cozza, C Franchin, G Arrigoni, L A Pinna.   

Abstract

Analyses of human phosphoproteome based on primary structure of the aminoacids surrounding the phosphor Ser/Thr suggest that a significant proportion of phosphosites is generated by a restricted number of acidophilic kinases, among which protein kinase CK2 plays a prominent role. Recently, new acidophilic kinases belonging to the Polo like kinase family have been characterized, with special reference to PLK1, PLK2, and PLK3 kinases. While some progress has been made in deciphering the PLK1-dependent phosphoproteome, very little is known about the targets of PLK2 and PLK3 kinases. In this report by using an in vitro approach, consisting of cell lysate phosphorylation, phosphoprotein separation by 2D gel electrophoresis and mass spectrometry, we describe the identification of new potential substrates of PLK2 and PLK3 kinases. We have identified and validated as in vitro PLK2 and PLK3 substrates HSP90, GRP-94, β-tubulin, calumenin, and 14-3-3 epsilon. The phosphosites generated by PLK3 in these proteins have been identified by mass spectrometry analysis to get new insights about PLKs specificity determinants. These latter have been further corroborated by an in silico analysis of the PLKs substrate binding region.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828320     DOI: 10.1016/j.bbapap.2012.07.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

Review 1.  Regulation of molecular chaperones through post-translational modifications: decrypting the chaperone code.

Authors:  Philippe Cloutier; Benoit Coulombe
Journal:  Biochim Biophys Acta       Date:  2013-02-28

2.  Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding.

Authors:  Jeanette Schwarz; Stefanie Schmidt; Olga Will; Tomas Koudelka; Kaja Köhler; Melanie Boss; Björn Rabe; Andreas Tholey; Jürgen Scheller; Dirk Schmidt-Arras; Michael Schwake; Stefan Rose-John; Athena Chalaris
Journal:  J Biol Chem       Date:  2013-12-13       Impact factor: 5.157

3.  Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.

Authors:  Cinzia Franchin; Christian Borgo; Luca Cesaro; Silvia Zaramella; Jordi Vilardell; Mauro Salvi; Giorgio Arrigoni; Lorenzo A Pinna
Journal:  Cell Mol Life Sci       Date:  2017-11-09       Impact factor: 9.261

4.  Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics.

Authors:  Yang Gao; Elena B Kabotyanski; Jonathan H Shepherd; Elizabeth Villegas; Deanna Acosta; Clark Hamor; Tingting Sun; Celina Montmeyor-Garcia; Xiaping He; Lacey E Dobrolecki; Thomas F Westbrook; Michael T Lewis; Susan G Hilsenbeck; Xiang H-F Zhang; Charles M Perou; Jeffrey M Rosen
Journal:  Cancer Res Commun       Date:  2021-12-27

Review 5.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

6.  Phosphorylation of synaptic GTPase-activating protein (synGAP) by polo-like kinase (Plk2) alters the ratio of its GAP activity toward HRas, Rap1 and Rap2 GTPases.

Authors:  Ward G Walkup; Michael J Sweredoski; Robert L Graham; Sonja Hess; Mary B Kennedy
Journal:  Biochem Biophys Res Commun       Date:  2018-07-24       Impact factor: 3.575

7.  Cytoskeletal architecture and cell motility remain unperturbed in mouse embryonic fibroblasts from Plk3 knockout mice.

Authors:  Daniel R Michel; Kyu-Shik Mun; Chia-Chi Ho; Peter J Stambrook
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-02

Review 8.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

9.  Detection of phospho-sites generated by protein kinase CK2 in CFTR: mechanistic aspects of Thr1471 phosphorylation.

Authors:  Andrea Venerando; Cinzia Franchin; Natasha Cant; Giorgio Cozza; Mario A Pagano; Kendra Tosoni; Ateeq Al-Zahrani; Giorgio Arrigoni; Robert C Ford; Anil Mehta; Lorenzo A Pinna
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

10.  Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5'AMP-Activated Kinase Inactivation.

Authors:  Valeria Tosello; Deborah Bongiovanni; Ludovica Di Martino; Cinzia Franchin; Paola Zanovello; Giorgio Arrigoni; Erich Piovan
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.